Consolidated statements of income and comprehensive income

Financial statements

Consolidated income statement

 

 

 

 

 

Year ended 31 December

 

(thousands of €, except share and per share data)

2017

2016

Notes

Revenues

127,087

129,519

5

Other income

28,830

22,093

5

Total revenues and other income

155,918

151,612

 

 

 

 

 

Research and development expenditure

(218,502)

(139,573)

6

General and administrative expenses

(24,415)

(21,744)

6

Sales and marketing expenses

(2,803)

(1,785)

6

Total operating expenses

(245,720)

(163,103)

 

 

 

 

 

Operating loss

(89,802)

(11,491)

 

 

 

 

 

Fair value re-measurement of share subscription agreement

57,479

8

Other financial income

4,877

9,950

9

Other financial expenses

(30,582)

(1,692)

9

 

 

 

 

Profit / loss (–) before tax

(115,507)

54,246

 

 

 

 

 

Income taxes

(198)

(235)

10

 

 

 

 

Net income / loss (–)

(115,704)

54,012

11

Net income / loss (–) attributable to:

 

 

 

Owners of the parent

(115,704)

54,012

 

Basic income / loss (–) per share

(2.34)

1.18

11

Diluted income / loss (–) per share

(2.34)

1.14

11

Weighted average number of shares – Basic (in thousands of shares)

49,479

45,696

11

Weighted average number of shares – Diluted (in thousands of shares)

49,479

47,308

 

Consolidated statement of comprehensive income

 

 

 

 

 

Year ended 31 December

 

(thousands of €)

2017

2016

Notes

Net income / loss (–)

(115,704)

54,012

 

Items that will not be reclassified subsequently to profit or loss:

 

 

 

Re-measurement of defined benefit obligation

(40)

(583)

28

Items that may be reclassified subsequently to profit or loss:

 

 

 

Fair value adjustment of available-for-sale financial assets

(220)

(399)

14

Translation differences, arisen from translating foreign activities

(664)

(623)

21

Other comprehensive income, net of income tax

(924)

(1,605)

 

 

 

 

 

Total comprehensive income attributable to:

 

 

 

Owners of the parent

(116,629)

52,406